- Home
- SEER vs ZTEK Comparison
SEER vs ZTEK Comparison
Compare SEER & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- ZTEK
- Stock Information
- Founded
- SEER 2017
- ZTEK 2008
- Country
- SEER United States
- ZTEK Canada
- Employees
- SEER N/A
- ZTEK N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- ZTEK Major Chemicals
- Sector
- SEER Health Care
- ZTEK Industrials
- Exchange
- SEER Nasdaq
- ZTEK Nasdaq
- Market Cap
- SEER 125.3M
- ZTEK 115.2M
- IPO Year
- SEER 2020
- ZTEK N/A
- Fundamental
- Price
- SEER $2.13
- ZTEK $1.08
- Analyst Decision
- SEER Hold
- ZTEK
- Analyst Count
- SEER 1
- ZTEK 0
- Target Price
- SEER $3.00
- ZTEK N/A
- AVG Volume (30 Days)
- SEER 138.6K
- ZTEK 34.0K
- Earning Date
- SEER 08-07-2025
- ZTEK 08-13-2025
- Dividend Yield
- SEER N/A
- ZTEK N/A
- EPS Growth
- SEER N/A
- ZTEK N/A
- EPS
- SEER N/A
- ZTEK N/A
- Revenue
- SEER $15,309,000.00
- ZTEK $607,016.00
- Revenue This Year
- SEER $26.18
- ZTEK N/A
- Revenue Next Year
- SEER $29.58
- ZTEK N/A
- P/E Ratio
- SEER N/A
- ZTEK N/A
- Revenue Growth
- SEER N/A
- ZTEK 2826.26
- 52 Week Low
- SEER $1.59
- ZTEK $0.50
- 52 Week High
- SEER $2.63
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- SEER 51.35
- ZTEK 30.17
- Support Level
- SEER $2.13
- ZTEK $1.04
- Resistance Level
- SEER $2.23
- ZTEK $1.20
- Average True Range (ATR)
- SEER 0.07
- ZTEK 0.09
- MACD
- SEER 0.00
- ZTEK -0.01
- Stochastic Oscillator
- SEER 53.97
- ZTEK 15.79
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.